Presence of Atrial Fibrillation at the Time of Dialysis Initiation Is Associated with Mortality and Cardiovascular Events

By  

Nephron, Vol. 132, Iss. 2, 2016-0 ,pp. : 86-92

Karger

Access to resources Recommend Favorite

Mortality and Associated Risk Factors in Dialysis Patients with Cardiovascular Disease

By  

Kidney and Blood Pressure Research, Vol. 41, Iss. 4, 2016-07 ,pp. : 479-487

Karger

Access to resources Recommend Favorite

Placental Growth Factor as a Novel Marker in Uremia-Related Cardiovascular Disease

By  

American Journal of Nephrology, Vol. 42, Iss. 2, 2015-0 ,pp. : 115-116

Karger

Access to resources Recommend Favorite

Is Fibroblast Growth Factor 23 the New Biomarker for Cardiovascular Mortality in Chronic Kidney Disease Patients?

By  

American Journal of Nephrology, Vol. 45, Iss. 2, 2016-12 ,pp. : 146-148

Karger

Access to resources Recommend Favorite

Fibroblast Growth Factor 23 Predicts All-Cause Mortality in a Dose-Response Fashion in Pre-Dialysis Patients with Chronic Kidney Disease

By  

American Journal of Nephrology, Vol. 45, Iss. 2, 2016-12 ,pp. : 149-159

Karger

Access to resources Recommend Favorite